Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
If you don’t know why, then watch this 1992 video of ACT UP’s Ashes Action outside the White House.
Photographer and ACT UP member Bill Bytsura guides us through his decades-in-the-making book.
The 1988 “Seize Control of the FDA” AIDS protest forced major change and announced the arrival of ACT UP. Original activists discuss it.
Old school AIDS activism had everything to do with an electrifying moment during the Kavanaugh hearings.
U.S. activists unveil a national action plan to #BreakThePatent. It points out that taxpayers funded the research behind Truvada as PrEP.
A provocative interview with author Sarah Schulman also reveals the most pressing issues facing gay people and the HIV community.
Many advocates and HIV organizations pay their respects to AIDS activist Mathilde Krim on social media.
And it’s not survivor’s guilt, explains ACT UP veteran turned film director Vincent Gagliostro.
HIV activists had called for his ouster over his handling of the Harvey Weinstein-related financial controversy at the nonprofit.
At stake in amfAR’s civil war is the nonprofit’s quest to find a cure for HIV.
Autumn offers a stellar lineup of HIV-related reading. Find these suggested titles in the POZ Bookstore:
Michael Friedman, best known for “Bloody Bloody Andrew Jackson,” reportedly found out he had HIV only nine weeks before his death.
He conquered Broadway, YouTube and Oz. Now he’s helping “Positively Fearless” tackle HIV in the Black community.
AIDS activists urge the N.Y. attorney general to investigate possible antitrust violations regarding the HIV med used as PrEP.
However, Gilead Sciences, the brand-name manufacturer of Truvada, insists a generic version “will not be immediately available.”
A roundup of social media statements, press releases, commentary and more. Let us know your thoughts.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.